Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 8, 2000, Pages 1017-1021

  Szekacs, Bela ^a   Vajo, Zoltan ^c   Varbiro, Szabolcs ^a   Kakucs, Reka ^a   Vaslaki, Lajos ^b   Acs, Nandor ^a   Mucsi, Istvan ^a   Brinton, Eliot A ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b City Hospital Sopron   (Hungary)

^c CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; ESTRADIOL; GLUCOSE; NORGESTREL; PROTEIN;

ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE CLEARANCE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS; THROMBOEMBOLISM;

BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA;

EID: 0033941056     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb10406.x     Document Type: Article

References (31)

1. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules Kidney Int 1990; 38:384–394.
2. Eddy AA, McCulloch L, Liu E, Adams J. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 1991; 138: 1111–1123.
3. Mori H, Yamashita H, Nakanishi C et al. Proteinuria induced by trans-plantable rat pituitary tumor MtTSA5. Model for homologous protein overload proteinuria. Lab Invest 1986; 54: 636–644.
4. Remuzzi G. Abnormal protein traffic thorough the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 1995; 4: 339–342.
5. Rossing P, Hommel E, Smidt UM, Parving HH. Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 1994; (Suppl. 45): S145–S149.
6. Gorodeski Gl. Utian WH. Epidemiology and risk factors of cardiovascular disease in postmenopausal women. In: Lobo RA, editor. Treatment of the Postmenopausal Woman. New York: Raven Press, 1994: p. 199–221.
7. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: 427–433.
8. Owens JF, Stoney CM, Matthews KA. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993; 88: 2794–2802.
9. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA 1998; 280: 605–613.
10. Meade TW. Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull 1992; 48: 276–308.
11. Nablusi AA, Folsom AR, White A et al. Association of hormone replacement therapy with various cardiovascular risk factors in post-menopausal women. N Engl J Med 1993; 328: 1069–1075.
12. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1992; 20: 47–53.
13. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1037.
14. Gerhard M, Walsh BW, Tawakol A et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998; 98: 1158–1163.
15. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998; 104: 552–558.
16. Espland MA, Hogan PE, Fineberg SE et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 1998; 21: 1589–1595.
17. Crepaldi G, Carta Q, Deferrari G et al. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. Diabetes Care 1998; 21: 104–110.
18. Iordaceh BE, Imberti O, Foglieni C, Remuzzi G, Bertani T, Remuzzi A. Effects of angiotensin-converting enzyme inhibition on glomerular capillary wall ultrastructure in MWF/Ztm rats. J Am Soc Nephrol 1994; 5: 1378–1384.
19. Edelman SV. Importance of glucose control. Med Clin North Am 1998; 82: 665–687.
20. Pervin S, Singh R, Rosenfeld ME, Navab M, Chaudhuri G, Nathan L. Estradiol suppresses MCP-1 expression In vivo: implications for atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 1575–1582.
21. Ghanam K, Javellaud J, Ea-Kim L, Oudart N. The protective effect of 17 beta-estradiol on vasomotor responses of aorta from cholesterol-fed rabbit is reduced by inhibitors of superoxide dismutase and catalase. Biochem Biophys Res Commun 28; 249: 858–864, 1998.
22. Seeger H, Mueck AO, Lippert TH. The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL. Int J Clin Pharmacol Ther 1998; 36: 383–385.
23. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthesis by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212–5216.
24. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993; 118: 429–432.
25. Trachtman H, Koss I, Bogart M et al. High glucose enhances growth factor-stimulated nitric oxide production by cultured rat mesangial cells. Res Commun Mol Pathol Pharmacol 1998; 100: 213–225.
26. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998; 54: 775–784.
27. Kakucs R, Varbiro S, Szekacs B, Nadasy GL, Acs N, Monos E. Direct relaxing effect of estradiol-17 beta and progesterone on rat saphenous artery. Microvasc Res 1998; 56: 139–143.
28. Acs N, Szekacs B, Nadasy GL et al. Effects of ovariectomy and progesterone or combined hormone replacement on small artery biomechanics [abstract]. FASEB J 1998; 12: A698.
29. Acs N, Szekacs B, Nadasy GL et al. Estrogen replacement reverses the effect of ovariectomy on small artery biomechanics [abstract]. FASEB J 1997; 11: A489.
30. Bhathena RK, Anklesaria BS, Ganatra AM. The treatment of hypertriglyceridaemia in menopausal women with transdermal oestradiol therapy. Br J Obstet Gynaecol 1999; 106: 980–982.
31. Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol. 1996; 16: 431–440.